Myelodysplastic Syndromes (MDS) are treated within GWCC’s Malignant Hematology Program. Myelodysplastic syndromes are a group of disorders caused by poorly formed or dysfunctional blood cells. Myelodysplastic syndromes occur when something goes wrong in your bone marrow — the spongy material inside your bones where blood cells are made.

Myelodysplastic Syndromes (MDS) is treated within the GW Malignant Hematology Program

Blood tubes with gloved hand picking one up
  • Comprehensive Cancer Care
  • The GW Cancer Center Malignant Hematology program  specializes in the diagnosis and treatment of various blood cancers and autoimmune disorders. For more information call (202) 741-2210. 

Malignant Hematology Program Providers

Kieron Dunleavy, MD
Specialty: Cancer & Blood Disorders
Faysal Haroun
Specialty: Cancer & Blood Disorders, Medicine
Robert Siegel, MD with patient
Specialty: Cancer & Blood Disorders
Dr. Mitchell Smith
Specialty: Cancer & Blood Disorders
Dr. Imad Tabbara
Specialty: Thoracic Cancer Care Program, Cancer & Blood Disorders